ViewRay Shares Slide to 52-Week Low After Guidance Cut

Dow Jones

Apr 13, 2023

By Colin Kellaher

Shares of ViewRay Inc. lost more than a third of their value and hit a new 52-week low on Thursday after the radiation therapy system maker slashed its revenue guidance and said it would explore strategic alternatives, including a sale of the company.

ViewRay said it now expects revenue will be flat to up 15% this year, compared with a prior growth forecast of 25% to 40%.

The company also said its adjusted Ebitda loss this year would be wider than previous estimates.

ViewRay said it hired Goldman Sachs & Co. as an adviser to review its options, including a possible sale, merger or business combination.

ViewRay shares were recently changing hands at $1.96, down 35%, after hitting a 52-week low of $1.92 earlier in the session.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

April 13, 2023 11:43 ET (15:43 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2327962159"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2327962159\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2327962159?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-04-13 23:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2327962159","market":"us","top_or_hot":-1,"title":"ViewRay Shares Slide to 52-Week Low After Guidance Cut","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ViewRay Inc. lost more than a third of their value and hit a new 52-week low on Thursday after the radiation therapy system maker slashed its revenue guidance and said it would explore strategic alternatives, including a sale of the company. \n</p>\n<p>\n  ViewRay said it now expects revenue will be flat to up 15% this year, compared with a prior growth forecast of 25% to 40%. \n</p>\n<p>\n  The company also said its adjusted Ebitda loss this year would be wider than previous estimates. \n</p>\n<p>\n  ViewRay said it hired Goldman Sachs &amp; Co. as an adviser to review its options, including a possible sale, merger or business combination. \n</p>\n<p>\n  ViewRay shares were recently changing hands at $1.96, down 35%, after hitting a 52-week low of $1.92 earlier in the session. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 13, 2023 11:43 ET (15:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ViewRay Shares Slide to 52-Week Low After Guidance Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViewRay Shares Slide to 52-Week Low After Guidance Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-04-13 23:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ViewRay Inc. lost more than a third of their value and hit a new 52-week low on Thursday after the radiation therapy system maker slashed its revenue guidance and said it would explore strategic alternatives, including a sale of the company. \n</p>\n<p>\n  ViewRay said it now expects revenue will be flat to up 15% this year, compared with a prior growth forecast of 25% to 40%. \n</p>\n<p>\n  The company also said its adjusted Ebitda loss this year would be wider than previous estimates. \n</p>\n<p>\n  ViewRay said it hired Goldman Sachs &amp; Co. as an adviser to review its options, including a possible sale, merger or business combination. \n</p>\n<p>\n  ViewRay shares were recently changing hands at $1.96, down 35%, after hitting a 52-week low of $1.92 earlier in the session. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 13, 2023 11:43 ET (15:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4552","symbol_name":"Archegos爆仓风波概念","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2327962159","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2327962159","pubTimestamp":1681400580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Colin Kellaher \n\n\n \n\n\n  Shares of ViewRay Inc. lost more than a third of their value and hit a ne","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4552":"Archegos爆仓风波概念","BK4082":"医疗保健设备","BK4127":"投资银行业与经纪业","BK4588":"碎股","BK4533":"AQR资本管理(全球第二大对冲基金)","GS":"高盛","BK4585":"ETF&股票定投概念","BK4504":"桥水持仓","BK4007":"制药","BK4191":"家用电器","CRCT":"Cricut, Inc.","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","TERN":"Terns Pharmaceuticals, Inc.","BK4550":"红杉资本持仓","BK4539":"次新股"},"translate_title":"指引下调后，ViewRay股价跌至52周低点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GS":0.88,"TERN":0.7,"VRAY":1,"CRCT":0.7},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Shares of ViewRay Inc. lost more than a third of their value and hit a new 52-week low on Thursday after the radiation therapy system maker slashed its revenue guidance and said it would explore strategic alternatives, including a sale of the company. \n\n\n  ViewRay said it now expects revenue will be flat to up 15% this year, compared with a prior growth forecast of 25% to 40%. \n\n\n  The company also said its adjusted Ebitda loss this year would be wider than previous estimates. \n\n\n  ViewRay said it hired Goldman Sachs & Co. as an adviser to review its options, including a possible sale, merger or business combination. \n\n\n  ViewRay shares were recently changing hands at $1.96, down 35%, after hitting a 52-week low of $1.92 earlier in the session. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 13, 2023 11:43 ET (15:43 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}